top of page
HealthGap Project

Nestlé faces backlash for adding sugar to baby cereals in poorer nations, exposing weak regulations and the urgent need for stronger public health protections.
HealthGap Project newsletter

Sky-high prices and monopolies around Ozempic and insulin show how diabetes care remains profit-driven, leaving fair access out of reach.
bottom of page
